HTML
-
There were 4, 553 participants who completed the questionnaire, and the biochemical and body composition examinations as well; 2, 344 of them were Han and 2, 209 were Bouyei. There were significant differences in the basic characteristics of the indicators between the Han and Bouyei groups (P < 0.05) (Table 1). Compared with the Han group, the Bouyei group was older, mostly from rural areas (85.29%), with a lower educational level, and exercised less frequently; however, more people in the Bouyei group were involved in heavy physical labor work and had smoking and drinking habits.
Variables Total Men Women Han Bouyei P Han Bouyei P Han Bouyei P Number of Cases 2.344 2.209 997 1.077 1.347 1.132 Age (y) 48.43 ± 14.08 49.80 ± 13.69 < 0.01 48.77 ± 13.72 49.88 ± 13.94 0.69 48.2 ± 14.35 49.72 ± 13.44 0.01 Regions < 0.01 < 0.01 < 0.01 Cities 1.464 (62.46) 321 (14.53) 637 (63.89) 138 (12.81) 827 (61.39) 183 (16.17) Villages 874 (37.29) 1.884 (85.29) 361 (36.21) 939 (87.19) 514 (38.16) 948 (83.75) Educational level < 0.01 < 0.01 < 0.01 Junior high school or below 1.331 (56.78) 1.718 (77.77) 500 (50.15) 786 (72.98) 831 (61.69) 932 (82.33) High school and above 1.003 (42.79) 479 (21.68) 492 (49.35) 288 (26.74) 511 (37.94) 191 (16.87) Manual labor < 0.01 < 0.01 < 0.01 Mild 1.654 (70.56) 842 (38.12) 616 (61.79) 353 (32.78) 1.038 (77.06) 489 (43.20) Moderate 227 (9.68) 131 (5.93) 149 (14.94) 81 (7.52) 78 (5.79) 50 (4.42) Heavy 461 (19.67) 1.231 (55.73) 231 (23.17) 640 (59.42) 230 (17.07) 591 (52.21) Exercise (day/week) < 0.01 < 0.01 < 0.01 0 1.339 (57.12) 1.904 (86.19) 572 (57.37) 903 (83.84) 767 (56.94) 1.001 (88.42) Monthly < 3 136 (5.80) 39 (1.77) 58 (5.82) 26 (2.41) 78 (5.79) 13 (1.15) 1-2 192 (8.19) 73 (3.3) 80 (8.02) 43 (3.99) 112 (8.31) 30 (2.65) 3-4 155 (6.61) 53 (2.40) 71 (7.12) 25 (2.32) 84 (6.24) 28 (2.47) 5-7 504 (21.50) 121 (5.40) 209 (20.96) 67 (6.22) 295 (21.90) 54 (4.77) Drinking < 0.01 0.03 < 0.01 Yes 868 (37.03) 982 (44.45) 682 (68.41) 783 (72.70) 186 (13.81) 199 (17.58) No 1.470 (62.71) 1.223 (55.36) 313 (31.39) 290 (26.93) 1.157 (85.89) 933 (82.42) Smoking < 0.01 0.14 0.10 Yes 675 (28.80) 752 (34.04) 648 (64.99) 733 (68.06) 27 (2.00) 19 (1.68) No 1.663 (70.95) 1.456 (65.91) 348 (34.90) 343 (31.85) 1.315 (97.62) 1.113 (98.32) Height (cm) 157.35 ± 8.32 155.36 ± 8.01 < 0.01 164.02 ± 6.29 161.01 ± 6.13 < 0.01 152.42 ± 5.82 149.98 ± 5.49 < 0.01 Weight (kg) 58.10 ± 10.84 53.24 ± 10.05 < 0.01 63.72 ± 10.42 57.38 ± 10.13 < 0.01 53.94 ± 9.13 43.30 ± 8.22 < 0.01 BMI 23.39 ± 3.49 21.96 ± 3.19 < 0.01 23.64 ± 3.34 22.05 ± 3.12 < 0.01 23.21 ± 3.59 21.88 ± 3.24 < 0.01 Body fat percentage (%) 27.78 ± 7.98 24.56 ± 8.05 < 0.01 21.45 ± 5.46 18.69 ± 5.42 < 0.01 32.51 ± 6.07 30.15 ± 5.86 < 0.01 Muscle mass (kg) 39.50 ± 7.77 37.85 ± 7.27 < 0.01 47.0 ± 5.39 43.79 ± 5.39 < 0.01 33.95 ± 3.33 32.20 ± 3.14 < 0.01 Body fat quantity (kg) 16.36 ± 6.16 13.27 ± 5.61 < 0.01 14.13 ± 5.43 11.17 ± 5.09 < 0.01 18.00 ± 6.15 15.27 ± 5.35 < 0.01 Grip strength (kg) 28.91 ± 9.36 28.50 ± 9.50 0.15 36.66 ± 7.92 34.71 ± 8.58 < 0.01 23.18 ± 5.37 22.60 ± 5.90 0.01 WC (cm) 79.10 ± 10.59 74.10 ± 9.80 < 0.01 81.60 ± 10.23 75.48 ± 10.03 < 0.01 77.25 ± 10.48 72.80 ± 9.39 < 0.01 Hip circumference (cm) 86.94 ± 6.59 83.17 ± 5.99 < 0.01 87.29 ± 6.22 83.27 ± 6.03 < 0.01 86.67 ± 6.83 83.07 ± 5.95 < 0.01 FBG (mmol/L) 5.19 ± 1.28 5.04 + 0.91 < 0.01 5.29 ± 1.35 5.17 ± 1.13 0.02 5.11 ± 1.22 4.92 ± 0.63 < 0.01 HDL (mmol/dL) 1.44 ± 0.33 1.60 ± 0.40 < 0.01 1.37 ± 0.34 1.58 ± 0.44 < 0.01 1.50 ± 0.32 1.62 ± 0.36 < 0.01 SBP (mmHg) 130.26 ± 20.81 133.66 ± 22.26 < 0.01 133.28 ± 19.19 136.76 ± 21.99 < 0.01 128.02 ± 21.66 130.71 ± 22.14 < 0.01 DBP (mmHg) 78.38 ± 11.92 78.98 ± 12.45 0.10 81.05 ± 11.84 81.53 ± 12.67 0.28 76.40 ± 11.59 76.45 ± 11.70 0.91 TG (mmol/dL) 1.74 ± 1.51 1.50 ± 1.47 < 0.01 1.99 ± 1.75 1.59 ± 1.85 < 0.01 1.55 ± 1.26 1.32 ± 0.93 < 0.01 Note. Continuous variables are expressed as mean ± SD and were compared using the t-test. Categorical variables are expressed as n (%) and were compared using the χ2 test. BMI: body mass index; WC: waist circumference; FBG: Fasting blood glucose; HDL: high-density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides. Table 1. General Characteristics of Participants from Han and Bouyei Populations from Guizhou, Southwest China
Regarding clinical features, there were no significant differences in grip strength and diastolic blood pressure. However, HDL-C and systolic blood pressure of the Bouyei group were significantly higher than that of the Han group. All other indicators were lower in the Bouyei group than in the Han group.
Sex-specific analysis showed no differences in smoking habits and diastolic blood pressure levels between the two ethnic groups. Women in the Bouyei group were older than women in the Han group. All other indicators were higher in the Han group compared with the Bouyei group.
-
Table 2 presents the crude prevalence rates for MetS and its components according to of the IDF's definition of MetS. Regardless of the overall or sex-specific situation, the prevalence of MetS and its components in the Han group were significantly higher than those in the Bouyei group (P < 0.01). Compared with other components, central obesity was the most prevalent component of MetS in the population from Guizhou. Comparisons between men and women showed no significant differences for high triglyceride levels (P = 0.18) and fasting blood glucose increases (or use of hypoglycemic drugs) (P = 0.10) between the sex; however, the prevalence of MetS, central obesity, low HDL-C, and hypertension (or use of antihypertensive drugs) for women were significantly higher than men.
Crude Prewalence Total Men Women P (Men vs. Women) Han Bouyei P Han Bouyei P Han Bouyei P Han Bouyei MetS 448 (19.11) 192 (8.69) < 0.01 155 (15.55) 77 (7.15) < 0.01 293 (21.75) 115 (10.16) < 0.01 < 0.01 0.01 Central obesity 722 (30.81) 349 (15.80) < 0.01 216 (21.66) 109 (10.12) < 0.01 506 (37.56) 240 (21.20) < 0.01 < 0.01 < 0.01 High TG 388 (16.55) 187 (8.47) < 0.01 153 (15.35) 85 (7.89) < 0.01 235 (17.44) 102 (9.01) < 0.01 0.18 0.35 Low HDL 247 (10.54) 83 (3.76) < 0.01 55 (5.52) 15 (1.39) < 0.01 192 (14.25) 68 (6.01) < 0.01 < 0.01 < 0.01 Hypertension 500 (21.33) 238 (10.77) < 0.01 151 (15.15) 81 (7.52) < 0.01 349 (25.91) 157 (13.87) < 0.01 < 0.01 < 0.01 Hyperglycemia 207 (8.83) 89 (4.03) < 0.01 77 (7.72) 42 (3.89) < 0.01 130 (9.65) 47 (4.15) < 0.01 0.10 0.76 Note. Data are presented as n (%) and compared using the χ2 test. MetS, metabolic syndrome; TG: triglycerides; HDL: high-density lipoprotein; P: P-value. Table 2. Crude Prevalence of Metabolic Syndrome and Its Components for Han and Bouyei Ethnicities
The age-standardized prevalence was calculated based on the calculated crude prevalence rate and the 2010 census data of Guizhou province (Table 3). The age-standardized prevalence of MetS was 11.38% (men: 9.76%; women 12.72%) for the Han group, and 4.78% (men: 4.43%; women: 5.30%) for the Bouyei group. Both Han and Bouyei groups were 40-49 years old when the prevalence peaked, and decreased with age.
Age-group (years) Total Han Bouyei Han Bouyei Men Women Men Women 20-29 5 (0.26) 2 (0.15) 87 (0.44) 2 (0.17) 2 (0.28) 0 (0) 30-39 61 (2.30) 30 (1.02) 188 (2.63) 31 (2.04) 20 (1.51) 10 (0.62) 40-49 123 (3.46) 62 (1.59) 259 (3.69) 64 (3.26) 30 (1.58) 32 (1.61) 50-59 123 (2.58) 55 (1.19) 209 (1.74) 87 (3.23) 19 (0.85) 36 (1.51) 60-69 98 (1.74) 33 (0.58) 183 (0.77) 79 (2.52) 4 (0.13) 29 (1.09) 70-80 38 (1.04) 10 (0.25) 71 (0.49) 30 (1.50) 2 (0.08) 8 (0.47) Age-standardized (%) 11.38 4.78 9.76 12.72 4.43 5.30 Note. Data are presented as n (%). Table 3. Age-standardized Prevalence of Metabolic Syndrome Based on the Criteria of the International Diabetes Federation
-
Table 4 presents the MetS types defined by the IDF standards. MetS types consist of central obesity along with other metabolic indicators. In the central obesity type combined with two components, hypertriglyceridemia plus hypertension (or use of antihypertensive drugs) was the most common regardless of sex or ethnicity. In the central obesity combined with three components, high triglycerides plus low HDL-C plus hypertension (or use of antihypertensive drugs) was the most common type for the Han group. Hypertension (or use of antihypertensive drugs) plus fasting hyperglycemia (or use of hypoglycemic drugs) plus high triglycerides was the most common type for the Bouyei group. High triglycerides plus hypertension (or use of antihypertensive drugs) plus fasting hyperglycemia (or use of hypoglycemic drugs) was the most common type for men. High triglycerides plus hypertension (or use of antihypertensive drugs) plus fasting hyperglycemia (or use of hypoglycemic drugs) was the most common type for women.
Characteristics of Metabolic Syndrome Total Men Women P (Men vs. Women) Han Bouvei P Han Bouyei P Han Bouyei P Han Bouyei WC+TG+HDL 167 (7.12) 61 (2.76) < 0.01 43 (4.31) 14 (1.30) < 0.01 124 (9.21) 47 (4.15) < 0.01 < 0.01 < 0.01 WC+TG+BP 282 (12.03) 144 (6.52) < 0.01 103 (10.33) 66 (6.13) < 0.01 179 (13.30) 78 (6.89) < 0.01 0.03 0.47 WC+TG+FBG 133 (5.67) 62 (2.81) < 0.01 56 (5.62) 37 (3.44) 0.02 77 (5.72) 25 (2.21) < 0.01 0.92 0.08 WC+HDL+BP 165 (7.04) 59 (2.67) < 0.01 32 (3.21) 11 (1.02) < 0.01 133 (9.87) 48 (4.24) < 0.01 < 0.01 < 0.01 WC+HDL+FBG 67 (2.86) 26 (1.18) < 0.01 17 (1.71) 7 (0.65) 0.03 50 (3.71) 19 (1.68) < 0.01 < 0.01 < 0.01 WC+BP+FBG 163 (6.95) 71 (3.21) < 0.01 57 (5.72) 35 (3.25) 0.01 106 (7.87) 36 (3.18) < 0.01 0.04 0.93 WC+TG+HDL+BP 118 (5.03) 47 (2.13) < 0.01 23 (2.31) 10 (0.93) 0.01 95 (7.05) 37 (3.27) < 0.01 < 0.01 < 0.01 WC+TG+HDL+FBG 57 (2.43) 22 (1.00) < 0.01 16 (1.60) 7 (0.65) 0.04 41 (3.04) 15 (1.33) < 0.01 0.03 0.11 WC+HDL+BP+FBG 52 (2.21) 20 (0.91) < 0.01 11 (1.10) 5 (0.46) 0.10 41 (3.04) 15 (1.33) < 0.01 < 0.01 0.03 WC+BP+FBG+TG 108 (4.61) 52 (2.35) < 0.01 43 (4.31) 32 (3.00) 0.10 65 (4.83) 20 (1.77) < 0.01 0.56 0.06 WC+TG+HDL+BP+FBG 47 (2.01) 17 (0.77) < 0.01 11 (1.10) 5 (0.46) 0.10 36 (2.67) 12 (1.06) < 0.01 0.01 0.11 Note. Data are presented as n (%). WC: Waist circumference; HDL: high-density lipoprotein; TG: triglycerides; BP: blood pressure; FBG: Fasting blood glucose. Table 4. Characteristics of Metabolic Syndrome
-
The FMR cut-off point for MetS was determined using the maximum Youden's index and the area under the ROC curve. For men, the FMR cut-off point was 0.34, and the area under the ROC curve was 0.95, while the sensitivity and specificity were 0.94 and 0.85, respectively. For women, the FMR cut-off point was 0.55, and the area under the ROC curve was 0.91, while the sensitivity and specificity were 0.93 and 0.79, respectively (Table 5, Figure 1).
Sex Positive Numbers Negative Numbers FMR Cut-off Point Sensitivity Specificity PPV NPV AUC 95% CI P Value Men 232 1, 842 0.34 0.94 0.85 0.44 0.99 0.95 0.94-0.96 < 0.01 Women 408 2, 071 0.55 0.93 0.79 0.46 0.98 0.91 0.90-0.93 < 0.01 Note. FMR: fat-to-muscle ratio; PPV: positive predictive value; NPV: negative predictive value; AUC: area under the curve; CI: confidence interval. Table 5. Receiver Operating Characteristic Curve Analysis of Fat-to-muscle Ratio for Diagnostic Prediction of Metabolic Syndrome
-
Participants were grouped by sex and risk factors for MetS were analyzed using multivariate logistic regression analysis with MetS as a dependent variable. Independent variables included age, ethnicity, region, BMI, hip circumference, grip strength, FMR (divided into two groups according to the cut-off points), history of hypertension, history of diabetes, exercise, manual labor, smoking or not, and drinking or not. The factors finally included in the model were age, hip circumference, history of diabetes, history of hypertension, BMI, and FMR (Table 6). Hip circumference, history of diabetes, BMI, and FMR were independent risk factors, regardless of sex or ethnicity. Compared with the FMR value below the cut-off point, people above the cut-off point had a much higher risk for MetS (men odds ratio: 6.90, 95% confidence interval: 3.09-15.39; women odds ratio: 10.44, 95% confidence interval: 5.65-19.28.
Sex Men Women OR (95% CI) P OR (95% CI) P Age 1.00 (0.98, 1.03) 0.86 1.05 (1.03, 1.06) < 0.01 Ethnicity 0.94 (1.13, 1.59) 0.82 0.92 (0.60, 1.41) 0.70 Region 0.93 (0.50, 1.72) 0.82 1.00 (0.60, 1.41) 0.92 BMI 1.34 (1.13, 1.59) < 0.01 1.28 (1.26, 1.41) < 0.01 Hip circumference 1.16 (1.08, 1.25) 0.00 1.00 (0.97, 1.04) 0.89 Grip strength 1.00 (0.96, 1.03) 0.93 1.03 (1.00, 1.07) 0.10 History of hypertension 1.24 (0.68, 2.24) 0.49 1.55 (1.00, 2.40) 0.05 History of diabetes 4.27 (1.53, 11.97) < 0.01 3.21 (1.39, 7.39) 0.01 Smoking 0.21 0.69 No 1.00 1.00 Yes 1.37 (0.84, 2.21) 0.75 (0.19, 2.97) Drinking 0.28 0.14 No 1.00 1.00 Yes 1.35 (0.78, 2.33) 1.46 (0.88, 2.40) Exercise (days/week) 0.91 0.75 0 1.00 1.00 Monthly < 3 0.75 (0.37, 1.52) 1.06 (0.65, 1.72) 1-2 0.71 (0.31, 1.64) 1.63 (0.79, 3.36) 3-4 0.89 (0.39, 2.08) 1.03 (0.47, 2.27) 5-7 0.96 (0.37, 2.51) 1.23 (0.52, 2.95) Manual labor 0.47 0.55 Mild 1.00 1.00 Moderate 0.94 (0.48, 1.85) 0.95 (0.50, 1.80) Heavy 0.61 (0.28, 1.34) 0.76 (0.46, 1.25) FMR 6.90 (3.09, 15.39) < 0.01 10.44 (5.65, 19.28) < 0.01 Note. OR: odds ratio; CI: confidence interval; FMR: fat-to-muscle-ratio (divided into two groups according to the cut-off points). Table 6. Multivariate Logistic Regression Analysis of Metabolic Syndrome